Stereoselective synthesis of 2-acetamido-1,2-dideoxynojirimycin (DNJNAc) and ureido-DNJNAc derivatives as new hexosaminidase inhibitors
作者:Alex de la Fuente、Teresa Mena-Barragán、Ronald A. Farrar-Tobar、Xavier Verdaguer、José M. García Fernández、Carmen Ortiz Mellet、Antoni Riera
DOI:10.1039/c5ob00507h
日期:——
2-Acetamido-1,2-dideoxyiminosugars are selective and potent inhibitors of hexosaminidases and therefore show high therapeutic potential for the treatment of various diseases, including several lysosomal storage disorders. A stereoselective synthesis of 2-acetamido-1,2-dideoxynojirimycin (DNJNAc), the iminosugar analog of N-acetylglucosamine, with a high overall yield is here described. This novel procedure
2-乙酰氨基-1,2-二脱氧亚氨基糖是己糖胺酶的选择性和有效抑制剂,因此显示出用于治疗多种疾病(包括几种溶酶体贮积症)的高治疗潜力。本文描述了具有高总收率的2-乙酰氨基-1,2-二脱氧野oji霉素(DNJNAc)(N-乙酰氨基葡糖的亚氨基糖类似物)的立体选择性合成。该新方法还允许通过关键关键中间体上的内环胺衍生化获得脲基-DNJNAc共轭物。值得注意的是,某些脲基-DNJNAc代表可作为β-己糖胺酶的有效抑制剂和选择性抑制剂,包括人类酶,是中性sp 2的首例。-亚氨基糖型抑制剂报道了这些酶。此外,新的脲基-DNJNAc的两亲特性有望带来更好的药物样特性。